These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 19903431)

  • 1. [Pyoderma gangrenosum--clinical, laboratory and therapeutic approaches. Review of 28 cases].
    Duarte AF; Nogueira A; Lisboa C; Azevedo F
    Dermatol Online J; 2009 Jul; 15(7):3. PubMed ID: 19903431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pyoderma gangrenosum: a report of 15 cases and review of the literature].
    Suárez-Pérez JA; Herrera-Acosta E; López-Navarro N; Vilchez-Márquez F; Prieto JD; Bosch RJ; Herrera E
    Actas Dermosifiliogr; 2012 Mar; 103(2):120-6. PubMed ID: 21782147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features.
    Vidal D; Puig L; Gilaberte M; Alomar A
    J Dermatolog Treat; 2004 Jun; 15(3):146-52. PubMed ID: 15204146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pyoderma gangrenosum. 15 cases].
    Riahi I; Mokni M; Haouet S; Cherif F; El Euch D; Azaiz MI; Zitouna MM; Ben Osman-Dhahri A
    Ann Med Interne (Paris); 2001 Feb; 152(1):3-9. PubMed ID: 11240419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pyoderma gangrenosum associated with hidradenitis suppurativa: a case report and review of the literature].
    García-Rabasco AE; Esteve-Martínez A; Zaragoza-Ninet V; Sánchez-Carazo JL; Alegre-de-Miquel V
    Actas Dermosifiliogr; 2010 Oct; 101(8):717-21. PubMed ID: 20965015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up.
    Saracino A; Kelly R; Liew D; Chong A
    Australas J Dermatol; 2011 Aug; 52(3):218-21. PubMed ID: 21834821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophilic dermatoses: a review of current treatment options.
    Cohen PR
    Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An uncommon localization of pyoderma gangrenosum on the penis of an HIV infected patient in the Ivory Coast].
    Ecra E; Ahogo KC; Sangaré A; Kaloga M; Kassi K; Kouamé K; Kacou DE; Gbery IP; Yoboué YP; Kanga JM
    Bull Soc Pathol Exot; 2009 May; 102(2):85-7. PubMed ID: 19583026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyoderma gangrenosum: an Indian perspective.
    Bhat RM; Nandakishore B; Sequeira FF; Sukumar D; Kamath GH; Martis J; Furtado S
    Clin Exp Dermatol; 2011 Apr; 36(3):242-7. PubMed ID: 21070329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated superficial porokeratosis and pyoderma gangrenosum.
    di Meo N; Fluehler C; Perkan V; Trevisan G
    Dermatol Online J; 2010 Oct; 16(10):15. PubMed ID: 21062609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical tacrolimus for the treatment of localized, idiopathic, newly diagnosed pyoderma gangrenosum.
    Marzano AV; Trevisan V; Lazzari R; Crosti C
    J Dermatolog Treat; 2010 May; 21(3):140-3. PubMed ID: 19903010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease.
    Menachem Y; Gotsman I
    Isr Med Assoc J; 2004 Feb; 6(2):88-90. PubMed ID: 14986464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous pyoderma gangrenosum with hepatosplenic localization and monoclonal gammapathy. A case report].
    Delbrel X; Germain P; Fach J; Etienne G; Beylot C; Parrens M; De Mascarel A; Le Bras M; Longy-Boursier M
    Ann Med Interne (Paris); 2001 Feb; 152(1):65-7. PubMed ID: 11240430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pyoderma gangrenosum: report of 11 cases].
    López de Maturana D; Amaro P; Aranibar L; Segovia L
    Rev Med Chil; 2001 Sep; 129(9):1044-50. PubMed ID: 11725468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyoderma gangrenosum: an updated review.
    Ruocco E; Sangiuliano S; Gravina AG; Miranda A; Nicoletti G
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1008-17. PubMed ID: 19470075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: The Mayo Clinic experience, 1996 through 2013.
    Barbosa NS; Tolkachjov SN; El-Azhary RA; Davis MD; Camilleri MJ; McEvoy MT; Bridges AG; Wetter DA
    J Am Acad Dermatol; 2016 Nov; 75(5):931-939. PubMed ID: 27473454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: Treatment-resistant pyoderma gangrenosum.
    Kosari P; Feldman SR
    Dermatol Online J; 2012 Apr; 18(4):8. PubMed ID: 22559023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pyoderma gangrenosum: a report of 3 cases].
    Ma ZL; Zhang TL
    Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(21):1479-81. PubMed ID: 18275714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyoderma gangrenosum: study of 21 patients and proposal of a 'clinicotherapeutic' classification.
    Marzano AV; Trevisan V; Lazzari R; Crosti C
    J Dermatolog Treat; 2011 Oct; 22(5):254-60. PubMed ID: 20666672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
    Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
    Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.